Kenneth Hoberman Nuvectis Pharma, Inc. (NVCT) insider trading activity

Kenneth Hoberman is Director of Nuvectis Pharma, Inc.. Currently has a direct ownership of 103,140 shares of NVCT, which is worth approximately $637,405. The most recent transaction as insider was on Jun 13, 2024, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

41.02% 3M change

41.02% 12M change

Total Value Held $637,405

Kenneth Hoberman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2024	BUY Grant, award, or other acquisition	-	30,000 Added 22.53%	103,140 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	18,000 Added 19.75%	73,140 Common Stock
May 12 2022	BUY Open market or private purchase	$104,400 $17.4 p/Share	6,000 Added 9.81%	55,140 Common Stock

Also insider at

TGTX

TG THERAPEUTICS, INC. Healthcare

Director